Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $118.46M in Sales Revenues for its fiscal quarter ending in March of 2023.

Sales Change
Acadia Pharmaceuticals ACAD:US USD 118.46M 18.03M
Alnylam Pharmaceuticals ALNY:US USD 319.29M 15.74M
Biogen BIIB:US USD 2.46B 81M
BioMarin Pharmaceutical BMRN:US USD 596.42M 58.88M
Bristol-Myers Squibb BMY:US USD 11.34B 69M
Cara Therapeutics CARA:US USD 6.16M 2.9M
Corcept Therapeutics CORT:US USD 105.65M 2.6M
Cytokinetics CYTK:US USD 4.61M 2.66M
Eisai 4523:JP JPY 198.2B 10.63B
Eli Lilly LLY:US USD 6.96B 341.8M
Incyte Corp INCY:US USD 808.67M 118.03M
Intercept Pharmaceuticals ICPT:US USD 67.96M 9.26M
Intra Cellular Therapies ITCI:US USD 95.31M 7.44M
J&J JNJ:US USD 24.75B 1.04B
Marinus Pharmaceuticals MRNS:US USD 10.38M 3.22M
Moderna Inc MRNA:US USD 1.86B 3.22B
Neurocrine Biosciences NBIX:US USD 420.4M 8.4M
Pfizer PFE:US USD 18.28B 6.01B
Prothena PRTA:US USD 2.17M 47.75M
PTC Therapeutics PTCT:US USD 220.38M 52.97M
Sarepta Therapeutics SRPT:US USD 253.5M 4.93M
Seattle Genetics SGEN:US USD 519.72M 8.43M
Ultragenyx Pharmaceutical RARE:US USD 100.5M 2.85M
Vanda Pharmaceuticals VNDA:US USD 125M 60.51M
Vertex Pharmaceuticals VRTX:US USD 2.37B 72.1M